Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 16
2003 91
2004 72
2005 69
2006 92
2007 122
2008 188
2009 192
2010 156
2011 177
2012 160
2013 180
2014 221
2015 175
2016 142
2017 201
2018 251
2019 254
2020 221
2021 211
2022 153
2023 106
2024 55

Text availability

Article attribute

Article type

Publication date

Search Results

3,074 results

Results by year

Filters applied: . Clear all
Page 1
Updating the Definition of Cancer.
Brown JS, Amend SR, Austin RH, Gatenby RA, Hammarlund EU, Pienta KJ. Brown JS, et al. Mol Cancer Res. 2023 Nov 1;21(11):1142-1147. doi: 10.1158/1541-7786.MCR-23-0411. Mol Cancer Res. 2023. PMID: 37409952 Free PMC article.
Molecular Profiling of Metastatic Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes.
Alhalabi O, Hahn AW, Msaouel P, Andreev-Drakhlin AY, Meric-Bernstam F, Naing A, Piha-Paul S, Filip J, Pant S, Yap TA, Hong DS, Fu S, Karp D, Campbell E, Le H, Campbell MT, Shah AY, Tannir NM, Siefker-Radtke AO, Gao J, Roszik J, Subbiah V. Alhalabi O, et al. Mol Cancer Res. 2021 Mar;19(3):395-402. doi: 10.1158/1541-7786.MCR-20-0751. Epub 2020 Dec 15. Mol Cancer Res. 2021. PMID: 33323389
circ_0041732 Promotes Breast Cancer Progression.
Ye G, He S, Pan R, Zhu L, Zhou D, Cai G, Chen P. Ye G, et al. Mol Cancer Res. 2022 Oct 4;20(10):1561-1573. doi: 10.1158/1541-7786.MCR-21-1042. Mol Cancer Res. 2022. PMID: 35838496
Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment.
Sicotte H, Kalari KR, Qin S, Dehm SM, Bhargava V, Gormley M, Tan W, Sinnwell JP, Hillman DW, Li Y, Vedell PT, Carlson RE, Bryce AH, Jimenez RE, Weinshilboum RM, Kohli M, Wang L. Sicotte H, et al. Mol Cancer Res. 2022 Dec 2;20(12):1739-1750. doi: 10.1158/1541-7786.MCR-22-0099. Mol Cancer Res. 2022. PMID: 36135372 Free PMC article.
3,074 results